Systems and methods manually process blood and blood components in
sterile, closed environments, which further condition the blood
components for subsequent pathogen inactivation processes. The systems
and methods mate the manual collection of random donor platelet units
with the creation of larger therapeutic doses of platelets targeted to
undergo pathogen inactivation prior to long term storage and/or
transfusion.